earn recap mix result unexpect
mix shift away product revenu guidanc
expect alongsid pick back half
year also announc acquisit aporeto
view acqui-hir earli stage technolog
demonstr compani willing continu buy
product enhanc cloud platform feel mani
move part back half year becom prove
ground sale rep continu get speed mani
new product offer maintain buy rate price
highlight reiter buy recent travel
ceo director ir meet institut
investor came away increasingli comfort follow
residu valu estim chang ryder de-risk
estim remov key overhang stock go
forward expect investor start focu larg
untap market opportun transport outsourc
higher return potenti outsiz growth dedic
suppli chain segment on-going cost-reduct program
reiter buy rate pt ebitda low
end hist rang stephani benjamin
data show faster gain impli less reserv risk primari
layer interest see price inform broker
usi insur servic also ciab major broker trade
associ collect point acceler back half
increas expect report also
notabl highlight dispar upward pressur excess
layer cover larger loss kinsal jame
river less exposur given typic coverag limit
million maintain view
net beneficiari emerg price loss dynam mark
hc claim forefront sell season upbeat host
investor confer call yesterday ceo paul
savardi cfo dougla sharp compani reiter
two consecut quarter elev hc claim appear
statist anomali repres system
issu benefit plan posit earli momentum
sell season encourag core mid-market
account perform well reiter buy rate
electr power util
reflect ferc roe decis base lower impli roe
transmiss segment follow recent ferc decis
reduc estim due combin
lower estim higher peer valuat chang
price target ali agha
data show faster gain impli less reserv risk primari
layer interest see price inform broker
usi insur servic also ciab major broker trade
associ collect point acceler back half
increas expect report also
notabl highlight dispar upward pressur excess
layer cover larger loss kinsal jame
river less exposur given typic coverag limit
million maintain view
net beneficiari emerg price loss dynam mark
afternoon fda approv oxbryta formerli voxeltor
scd acceler approv basi significantli ahead
februari pdufa label rather broad
consist trial demograph efficacy/safeti result
report previous list price oxbryta per month
discount net price
major payer updat model rais pt
reiter buy joon
coverag drop coverag la jolla
pharmaceut compani result realloc
resourc last rate share hold research
issu date coverag termin
reli upon go forward joon
coverag drop coverag cymabay
therapeut inc result realloc
resourc last rate share hold research
issu date coverag termin
reli upon go forward joon
page
comput program system inc hold
 improv momentum sustain growth elus
pt maintain hold in-lin
expect think better add ep full
year est vs prior model share may see limit downsid
given annual dividend think near term ep
stabil said backlog book perform suggest
limit revenu upsid lower margin mix constrain ep
growth next year compound-annual-growth-rate sandi draper
weak quarter price/cost result substanti miss
straight quarter despit solid revenu growth price/cost
resi weak management discuss difficulti pass
supplier increas also believ price use tri
gain market share specif guidanc provid
yoy ebitda view somewhat
clear deck new ceo stori remain
oper organ growth turnaround believ
cfo departur last chang stock found
privat equiti floor test view
hc claim forefront sell season upbeat host
investor confer call yesterday ceo paul
savardi cfo dougla sharp compani reiter
two consecut quarter elev hc claim appear
statist anomali repres system
issu benefit plan posit earli momentum
sell season encourag core mid-market
account perform well reiter buy rate
retail reit reit adjust estim maintain pt
 updat earn
estim buy hold hold buy
sell base third quarter result post nareit
commentari earn confer call commentari adjust
revenu growth expens assumpt maintain
price target ki bin
rais ffo estim price target slightli
page
impli total return stock next month
highest project five-year ffop growth rate
offic coverag univers also trade highest
ffo fad multipl discount
consider narrow mani cbd offic peer closer
histor averag like growth high qualiti
company/portfolio/manag stock
averag perform ytd vs rmz think
estim price maintain hold rais
normal ffo estim price target follow good
result recent meet manag although
stock alreadi under-perform apart reit
ytd versu rmz believ valuat appear
fair notwithstand same-stor growth near top tightly-
bunch peer group project roughli averag earn growth
go averag multipl premium
versu sector averag price target
impli total return next month michael
earn recap mix result unexpect
mix shift away product revenu guidanc
expect alongsid pick back half
year also announc acquisit aporeto
view acqui-hir earli stage technolog
demonstr compani willing continu buy
product enhanc cloud platform feel mani
move part back half year becom prove
ground sale rep continu get speed mani
new product offer maintain buy rate price
inc hold complet stage one
licens renew oper normal appeal
highlight reiter buy recent travel
ceo director ir meet institut
investor came away increasingli comfort follow
residu valu estim chang ryder de-risk
estim remov key overhang stock go
forward expect investor start focu larg
untap market opportun transport outsourc
higher return potenti outsiz growth dedic
suppli chain segment on-going cost-reduct program
page
reiter buy rate pt ebitda low
end hist rang stephani benjamin
page
dec corp ndr ceo svp financ interim cfo presid pvg director
dec strh maxin relaxin summit boston
page
dec patrick schole barri jona lodg leisur game new york
dec youssef squali nave khan idm minneapoli new
page
issu research report suntrust robinson humphrey inc analyst name report herebi certifi
recommend opinion express accur reflect research analyst person view
subject secur compani discuss herein part research analyst compens directli
indirectli relat specif recommend view express report
